en

Vitrotest Bioreagent LLC continues investing in the economy of Ukraine and it’s future.

Vitrotest Bioreagent LLC continues investing in the economy of Ukraine and it’s future. Since the beginning of the war, the team of Vitrotest Bioreagent LLC has continued developing new test kits for the diagnostics of human allergic diseases.
Currently, Vitrotest® Total-IgE, a test kit for the quantitative determination of total immunoglobulin E has been elaborated and put into production. Calibrators of ELISA kit are standardized according to the Immunoglobulin E(IgE) human serum (3rd International Standard), code: 11/234 (NIBSC, Great Britain). The coefficient of determination R2 is 0.996.

The elaborated kit as well as other Vitrotest products are available at a stock in Ukraine.